1 year return (CAGR)
4.65%
Geron Corporation Exchange (NASDAQ, USD)
GERN
1.35
-0.02 (-1.46%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-18.02%
5 year return (CAGR)
-2.09%
10 year return (CAGR)
-6.66%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
867.34M
Price/Sales
4.24
Ent value
1.11B
Price/Book
3.97
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
33.75
EPS growth
-14.31%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.38 |
| Daily high | 1.41 |
| Daily low | 1.34 |
| Daily Volume | 5.01M |
| All-time high | 65.99 |
| 1y analyst estimate | 4.25 |
| Beta | 0.59 |
| EPS (TTM) | -0.10 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| GERN | S&P500 | |
| Current price drop from All-time high | -97.95% | -1.75% |
| Highest price drop | -98.66% | -56.47% |
| Date of highest drop | 18 Mar 2020 | 9 Mar 2009 |
| Avg drop from high | -86.17% | -10.68% |
| Avg time to new high | 244 days | 12 days |
| Max time to new high | 6669 days | 1805 days |
News
